Skip to content

Psilocybin: all studies

Page 130 of 440: studies 1,291 to 1,300 of 4,392, newest first. Back to the psilocybin overview

Research

Cognitive liberty and the constitutionality of criminalising psilocybin mushrooms in South Africa

South African Journal on Human Rights January 2, 2023 Sebastian William Foster 3 citations

The principle of cognitive liberty is assessed as a ground for challenging the constitutionality of the criminalisation of psilocybin mushrooms. To do so, s 12 of the Constitution of the Republic of South Africa, 1996, is analysed, determining that s 12(2) is not a numerus clausa and is capable of enforcing further protections and/or entitlements, such as cognitive liberty. Further, it is...

Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data

The Transmitter 2023 Peter Hess

Welcome to the April edition of Going on Trial, a monthly newsletter covering clinical trials and drug development for autism and related conditions.In this issue, we're talking about a serotonin agonist's path to trial for autism, debate around a trial of psilocybin for fragile X syndrome and an analysis of placebo responses in a clinical trial of the vasopressin blocker balovaptan.Feel free...

Tips and Recommendations for The Ingestion of Psilocybin: An Introduction to Community-Based Public Health Guidance for Lower Risk Psilocybin Use

Knowledge Commons (Lakehead University) 2023 Ashmita Grewal, Kalysha Closson, Logan White et al.

The purpose of this report is to provide community-based guidance for lower-risk psilocybin use. It is our hope that this guidance will help individuals considering or currently using psilocybin to have a positive and safe experience. The recommendations provided are based on results from the TRIP study (Tips and Recommendation for the Ingestion of Psilocybin), which we present in this report....

DOI: 10.17613/4jr9s-56m80 (opens in new tab) Psilocybin Public health Consumption sociology Ingestion +3

Translational research investigating psilocybin

2023 Manon M.j. van den Berg

This dissertation has taken an interdisciplinary approach to investigate and give insights into psilocybin’s neurobiological underpinnings. Psilocybin is a naturally occurring serotonergic psychedelic and is the main ingredient in hallucinogenic mushrooms. Research has demonstrated that psilocybin profoundly activates the serotonin (5-hydroxytryptamine) 2A (5-HT2A) receptors. Upon activation of...

Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature review

IJS - International Journal of Sciences 2023 Fabiano F. Da Silva, Thaysa Adriane Costa Bernardo, Johny Ricarte Das Silva Rodrigues et al. 1 citation

Psilocybin in the treatment of generalized anxiety disorder has become a strong point since it can have important benefits in the treatment. The general objective of the present study is to review the literature on the use of psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking, in order to compile and analyze the available evidence on its efficacy, safety...

The right to privacy in the decriminalisation of psilocybin mushrooms in South Africa

Law Democracy & Development 2023 Sebastian William Foster 2 citations

This article assesses the right to privacy as a ground for challenging the constitutionality of the criminalisation of psilocybin mushrooms. In doing so, it discusses the right to privacy as found in section 14 of the Constitution of the Republic of South Africa, 1996 (Constitution). Drawing on Constitutional Court case law, the article argues that the right to privacy is a fundamental right...

DOI: 10.17159/2077-4907/2023/ldd.v27.1 (opens in new tab) Full text (opens in new tab) Constitutionality Decriminalization Law Right to privacy +4

Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use

Drug Science, Policy and Law 2023 Brian S. Barnett, Noah Wiles Sweat, Peter S. Hendricks 6 citations

Background Recent survey data indicate that some people report long-term improvement in color vision deficiency (CVD), also known as color blindness, following use of psychedelics such as lysergic acid diethylamide (LSD) and psilocybin. However, there are no objective data reported in the medical literature quantifying the degree or duration of CVD improvement associated with psychedelic use....

DOI: 10.1177/20503245231172536 (opens in new tab) Psilocybin Hallucinogen Generalizability theory

Magic Mushrooms

The Meducator 2023 Alam Mehrjerdi Zahra, Bhavana Soma 2 citations

Psilocybin is a naturally occurring compound present in numerous mushroom species characterised by its hallucinogenic and psychedelic effects. Although it has a negative reputation, psilocybin has demonstrated therapeutic potential for treating mental health disorders by allowing the brain to make new neural connections which help the neural pathways adapt and break out of certain cognitive...